INS and diabetes mellitus: Compared with those of the development cohort, the participants of the external validation cohort were generally in an advanced stage of diabetes, were older, had a higher rate of insulin use and multi-antihyperglycemic agents, and had higher fasting glucose levels than those of the original NHIS cohort.